The Comparison of Hospitalization Records of Patients with Syphilis in 2007–2009 and 2017–2019

Česká verzia

Authors: I. Kuklová ¹; M. Kojanová ¹; M. Důra ¹; H. Záveská ¹; R. Pánková ¹; M. Kreidlová ²; D. Šmajs ³; E. Vrbová ³
Authors place of work: Dermatovenerologická klinika, 1. lékařská fakulta, Univerzita Karlova a Všeobecná fakultní nemocnice, Praha, přednosta prof. MUDr. Jiří Štork, CSc. ¹; Ústav klinické biochemie a laboratorní diagnostiky, 1. lékařská fakulta, Univerzita Karlova a Všeobecná fakultní, nemocnice, Praha, přednosta prof. MUDr. Tomáš Zima, DrSc., MBA ²; Biologický ústav, Lékařská fakulta, Masarykova univerzita, Brno, přednosta prof. RNDr. Ondřej Slabý, Ph. D. ³
Published in the journal: Čes-slov Derm, 96, 2021, No. 3, p. 124-132
Category: Pharmacologyand Therapy, Clinical Trials

Summary

The aim of the study was to evaluate clinical, epidemiological and demographic data of patients treated with syphilis at the Department of Dermatovenereology of the 1st faculty of medicine and General University Hospital in Prague (STD centre) in 2017–2019 and compare them with the previous survey carried out in 2007–2009 and with the nationwide data from the Czech Registry of veneral diseases and the european data from the European Surveillance System of the ECDC.

A total of 325 patients (83,4 % men and 16,6 % women) were hospitalized during the period 2017–2019. The total number of hospitalised patients decreased by 148 cases (31.3 %), the decrease was more pronounced in the female group (61.2%) as compared to the male group (18.9%). The increase of the male-to-female ratio is statistically significant (p < 0.001). The patients’ age has not changed in the long term, most of them were aged between 30 and 40. The percentage of foreigners was 26.5% and did not change significantly. In the male group, the proportion of primary syphilis decreased (24.4% vs 32.0 %; p = 0.046) and there was a significant increase in the number of HIV-positive patients (7.7% vs 3.0 %; p = 0.017), while the proportion of homo/bisexual men remained approximately the same (p = 0.934). The proportion of homo/bisexual men was 48.4% of all patients and 58.3% of men. In the female group, the number of primary and secondary syphilis cases was low and this proportion did not change significantly. Similarly, the proportion of pregnant women did not change significantly either (p = 0.371). The testing of samples for macrolide resistance showed a significant decrease in the number of sensitive strains (9.5% vs 57.6%).

Accurate and continuous collection of epidemiological and clinical data is necessary for trend analysis and targeted syphilis prevention. Our as well as European data show that men having sex with men are the most vulnerable group. Regular screening for syphilis and other sexually transmitted infections must be a priority in this group, regardless of the HIV status.

Keywords:

Syphilis – Epidemiology – Treponemu pallidum subsp. pallidum – allelic profiles

Zdroje

1. BOLAN, R. K., BEYMER, M. R., WEISS, R. E., FLYNN, R. P., LEIBOWITZ, A. A., KLAUSNER, J. D. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: A randomized, controlled pilot study. Sex trans dis, 2015, 42(2), p. 98–103.

2. Center for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2015. MMWR, 2015, 64, p. 13–16.

3. CHEW, N. G. R. A., SAMUEL, M. C., LO, T. et al. Sex, drugs (methamphetamines), and the Internet: increasing syphilis among men who have sex with men in California, 2004–2008. Am J Public Health, 2013, 103(8), p. 1450–1456.

4. DESILVA, M., HEDBERG, K., ROBINSON, B., TOEVSK, K. et al. A case-control study evaluating the role of internet meet-up sites and mobile telephone applications in influencing a syphilis outbreak: Multnomah County, Oregon, USA 2014. Sex Trans Inf, 10.1136/sextrans-2015-052509, published online May 17 2016.

5. DLOUHÝ, P. Pracovní postup pro poskytování preexpoziční profylaxe (PrEP) infekce lidským virem imunodeficience (HIV): Dokument pracovní skupiny lékařů HIV center České republiky [online] [cit. 2018-05-30]. Dostupné na www: https://www.infekce.cz/PPPrEP18.htm. accessed.

6. European Centre for Disease Prevention and Control. Evidence brief: Pre-exposure prophylaxis for HIV prevention in Europe. ECDC, 2016.

7. European Centre for Disease Prevention and Control. Surveillance systems overview. ECDC, 2019.

8. FDA. Truvada for PrEP Fact Sheet: Ensuring Safe and Proper Use. 2012. Dostupné na www: http://www.fda.gov/downloads/NewsEvents/Newsroom/FactSheets/UCM312279.pdf

9. FLEMING, D. T., WASSERHEIT, J. N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect, 1999, 75, p. 3–17.

10. GRANT, J. S., CHRYSOVALANTIS STAFYLIS, CONNIE CELUM, C., GRENNAN, T., HAIRE, B., KALDOR, J., FLUETKEMEYER, A. F., SAUNDERS, J. M., MOLINA, J. M., KLAUSNER, J. D. Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections. Clinical Infectious Diseases, 2020, 70(6), p. 1247–1253.

11. GRARUP, J., RAPPAPORT, C., ENGEN, N. et al. Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med, 2015, 16, p. 14–23.

12. GRILLOVÁ, L., BAWA, T., MIKALOVÁ, L., GAYETA-GERON, A., NIESELT, K., STROUHAL, M., SEDNAOUI, P., FERRY, T., CAVASSINI, M., LAUTENSCHLA-GER, S., DUTLY, F., PLA-DÍAZ, M., KRÜTZEN, M., GONZÁLEZ-CANDELAS, F., BAGHERI, HC., ŠMAJS, D., ARORA, N., BOSSHARD, PP. Molecular characterization of Treponema pallidum subsp. pallidum in Switzerland and France with a new multilocus sequence typing scheme. PLoS One, 2018, 13(7), e0200773.

13. JANIER, M., HEGYI, V., DUPIN, N., UNEMO, M. et al. European guideline on the management of syphilis. J Eur Acad Dermatol Venerol, 2014, 28, p.1581–1593.

14. JANSEN, K., STEFFEN, G., POTTHOF, A. et al. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany. BMC Infect Dis, 2020, 110. Dostupné na www: https://doi.org/10.1186/s12879-020-4831-4.

15. KIMBALL, A., MIELE, K., BACHMANN, L., THOPRE, P., WEINSTOCK, H., BOWEN, V. Missed opportunities for prevention of congenital syphilis. MMWR, 2020, 69, p. 661–665.

16. KOJIMA, N., KLAUSNER, J. D. An update on the global epidemiology of syphilis. Curr Epidemiol Rep, 2018, 5, p. 24–38.

17. KUKLOVÁ, I., KOJANOVÁ, M., ZÁKOUCKÁ, H., PÁNKOVÁ, R., VELČEVSKÝ, P., ROZEHNALOVÁ, Z., HERCOGOVÁ, J. Dermatovenereology in the post-communist era: Syphilis in Prague during 1999 to 2005. Dermatologic Clinics, 2008, 26, p. 231–237.

18. LI, Y., LI, J., HU, W., LUO, H., ZHOU, J., LI, C., CHEN, C. Gene subtype analysis of Treponema pallidum for drug resistance to azithromycin. Exp Ther Med, 2018, 16(2), p. 1009–1013.

19. MALÝ, M., NĚMEČEK, V., ZÁKOUCKÁ, H. Výskyt a šíření HIV/AIDS v ČR v roce 2018. Zprávy z Centra Epidemiologie a mikrobiologie, SZÚ, 2019, 28(8).

20. MCCORMACK, S., DUNN, D. T., DESAI, M., DOLLING, D. I., GAFOS, M., GILSON, R. et al. Preexposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet, 2016, 387, p. 53–60.

21. MOLINA, J. M., CAPITANT, C., SPIRE, B., PIALOUX, G., COTTE, L., CHARREAU, I. et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med, 2015, 373, p. 2237–2246.

22. MOLINA, J. M., CHARREAU, I., CHIDIAC, C., PILALOUX, G., CUA, E., DELAUGERRE, C. et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet, 2018, 18(3), p. 308-17. 262.

23. NGUYEN, V. K., GREENWALD, Z. R., TROTTIER, H. et al. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS, 2018, 32(4), p. 523–530.

24. PETTY-SAPHON, N., BRADY, M., CULLEN, G., COONEY, F., DOWNES, P., DOYLE, S., HOLDER, P., LYONS, F., IGOE, D. A proposal for changes to the Euro-pean Union syphilis surveillance case definition using evidence from evaluations in Ireland. Euro Surveill, 2019, 24(45).

25. POSPÍŠILOVÁ, P., GRANGE, P.A., GRILLOVÁ, L., PAŠTĚKOVÁ, L., MARTINET, P., JANIER, M., VERMERSCH, A., BENHADDOU, N., DEL GIUDICE, P., ALCARAZ, I., TRUCHETET, F., DUPIN, N., ŠMAJS, D. Multi-locus sequence typing of Treponema pallidum subsp pallidum present in clinical samples from France: Infecting treponemes are genetical-ly diverse and belong to 18 allelic profiles. Plos One, 2018, 13(7), p. 1–17.

26. REFUGIO, O. N., KLAUSNER, J. D. Syphilis incidence in men who have sex with men with human immunodeficiency virus comorbidity and the importance of integrating sexually transmitted infection prevention into HIV care. Expert Rev Anti Infect Ther, 2018, 16(4), p. 321–331.

27. RESL, V. a kol. Základy depistáže a organizace venerologické práce. 1. vyd. Západočeská univerzita v Plzni, 2019, 459 s. ISBN 978-80-261-0875-7.

28. SCOTT, H. M., LAUSNER, J. D. Sexually transmitted infections and pre-exposure prophylaxis: Challenges and opportunities among men who have sex with men in the US. AIDS Res Ther, 2016, p. 13:5.

29. SENCHAUDHURI, P., MEHTA, C. R., PATEL, N. R. Estimating Exact Values by the Method of Control Variates or Monte Carlo Rescue. Journal of the American Statistical Association, 1995, 90, 430, p. 640–648.

30. SELLATI, T. J., WILKINSON, D. A., SHEFFIELD, J. S. et al. Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1. J. Infect Dis, 2000, 181, p. 283–293.

31. SPITERI, G., UNEMO, M., MARDH, O., AMATO-GAUCI, A. J. The resurgence of syphilis in high-income countries in the 2000’s: A focus on Europe. Epidemiol Infect, 2019, 147, p. e143.

32. STAMM, L. V. Global challenge of antibiotic-resistant Treponema pallidum. Antimicrob Agents Chemother, 2010, 54(2), p. 583–589.

33. TRAEGER, M.W. et al. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection. JAMA, 2019, 321, p. 1380–1390.

34. Ústav zdravotnických informací a statistiky ČR, ÚZIS. Pohlavní nemoci. Dostupné na www: http://www.uzis.cz/

35. VRBOVÁ, E., GRILLOVÁ, L., MIKALOVÁ, L., POSPÍŠILOVÁ, P., STRNADEL, R., DASTYCHOVÁ, E. et al. MLST typing of Treponema pallidum subsp. palli-dum in the Czech Republic during 2004–2017: Clinical isolates belonged to 25 allelic profiles and harbored 8 novel allelic variants. PLoS One, 2019, 14(5), p. e0217611.

36. WILSON, D. P., PRESTAGE, G. P., GRAY, R. T., HOARE, A., MCCANN, P., DOWN, I. et al. Chemoprophylaxis is likely to be acceptable and could mitigate syphilis epidemics among populations of gay men. Sex trans dis, 2011, 38(7), p. 573–579.

37. ZABLOTSKA, I. B., O‘CONNOR, C. C. Preexposure prophylaxis of HIV infection: The role of clinical practices in ending the HIV epidemic. Curr HIV/AIDS Rep, 2017, 14(6), p. 201–210.